GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Encompass Health Corp (NYSE:EHC) » Definitions » ROE %

Encompass Health (Encompass Health) ROE %

: 21.85% (As of Dec. 2023)
View and export this data going back to 1989. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Encompass Health's annualized net income for the quarter that ended in Dec. 2023 was $350 Mil. Encompass Health's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $1,604 Mil. Therefore, Encompass Health's annualized ROE % for the quarter that ended in Dec. 2023 was 21.85%.

The historical rank and industry rank for Encompass Health's ROE % or its related term are showing as below:

EHC' s ROE % Range Over the Past 10 Years
Min: 16.82   Med: 25.68   Max: 44.21
Current: 23.86

During the past 13 years, Encompass Health's highest ROE % was 44.21%. The lowest was 16.82%. And the median was 25.68%.

EHC's ROE % is ranked better than
89.47% of 608 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs EHC: 23.86

Encompass Health ROE % Historical Data

The historical data trend for Encompass Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encompass Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.29 19.33 23.56 16.82 23.80

Encompass Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.30 26.04 25.58 22.48 21.85

Competitive Comparison

For the Medical Care Facilities subindustry, Encompass Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encompass Health ROE % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's ROE % distribution charts can be found below:

* The bar in red indicates where Encompass Health's ROE % falls into.



Encompass Health ROE % Calculation

Encompass Health's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=352/( (1310.3+1647.5)/ 2 )
=352/1478.9
=23.80 %

Encompass Health's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=350.4/( (1560.4+1647.5)/ 2 )
=350.4/1603.95
=21.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Encompass Health  (NYSE:EHC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=350.4/1603.95
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(350.4 / 4987.2)*(4987.2 / 6033.35)*(6033.35 / 1603.95)
=Net Margin %*Asset Turnover*Equity Multiplier
=7.03 %*0.8266*3.7616
=ROA %*Equity Multiplier
=5.81 %*3.7616
=21.85 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=350.4/1603.95
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (350.4 / 659.2) * (659.2 / 759.6) * (759.6 / 4987.2) * (4987.2 / 6033.35) * (6033.35 / 1603.95)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.5316 * 0.8678 * 15.23 % * 0.8266 * 3.7616
=21.85 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Encompass Health ROE % Related Terms

Thank you for viewing the detailed overview of Encompass Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Encompass Health (Encompass Health) Business Description

Traded in Other Exchanges
Address
9001 Liberty Parkway, Birmingham, AL, USA, 35242
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Executives
Douglas E Coltharp officer: EVP, Chief Financial Officer C/O UNDER ARMOUR, INC., 1020 HULL STREET, BALTIMORE MD 21230
Elissa Joy Charbonneau officer: Chief Medical Officer 24 HAWTHORNE CIRCLE, YARMOUTH ME 04096
Mark J Tarr officer: Executive VP Operations C/O ENCOMPASS HEALTH CORPORATION, 9001 LIBERTY PARKWAY, BIRMINGHAM AL 35242
Greg D Carmichael director
Kevin J. O'connor director 13995 PASTEUR BOULEVARD, PALM BEACH GARDENS FL 33418
Terrance Williams director 7184 BIDDICK, NEW ALBANY OH 43054
Christopher R Reidy director ONE ADP BLVD, ROSELAND NJ 07068
Andrew L Price officer: Interim Chief Accting Officer 3660 GRANDVIEW PARKWAY, SUITE 200, BIRMINGHAM AL 35243
Barbara Ann Jacobsmeyer officer: EVP, Operations 2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Donald L Correll director C/O INTERCHANGE FINANCIAL SERVICES CORP, PARK 80 W PLAZA TWO, SADDLE BROOK NJ 07663
Anthony April Kaye Bullock officer: CEO and President, Encompass 3606 PRINCETON AVENUE, DALLAS TX 75205
Higdon Leo I Jr director 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Patricia Anne Maryland director 7342 HORIZON DRIVE, WEST PALM BEACH FL 33412
Yvonne M Curl director C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Cheryl B. Levy officer: Chief Human Resources Officer 3137 BROOK HIGHLAND DRIVE, BIRMINGHAM AL 35242